1.Hypothermia Inhibits Endothelium-Independent Vascular Contractility via Rho-kinase Inhibition.
Yoon Hee CHUNG ; Keon Woong OH ; Sung Tae KIM ; Eon Sub PARK ; Hyun Dong JE ; Hyuk Jun YOON ; Uy Dong SOHN ; Ji Hoon JEONG ; Hyen Oh LA
Biomolecules & Therapeutics 2018;26(2):139-145
The present study was undertaken to investigate the influence of hypothermia on endothelium-independent vascular smooth muscle contractility and to determine the mechanism underlying the relaxation. Denuded aortic rings from male rats were used and isometric contractions were recorded and combined with molecular experiments. Hypothermia significantly inhibited fluoride-, thromboxane A2-, phenylephrine-, and phorbol ester-induced vascular contractions regardless of endothelial nitric oxide synthesis, suggesting that another pathway had a direct effect on vascular smooth muscle. Hypothermia significantly inhibited the fluoride-induced increase in pMYPT1 level and phorbol ester-induced increase in pERK1/2 level, suggesting inhibition of Rho-kinase and MEK activity and subsequent phosphorylation of MYPT1 and ERK1/2. These results suggest that the relaxing effect of moderate hypothermia on agonist-induced vascular contraction regardless of endothelial function involves inhibition of Rho-kinase and MEK activities.
Animals
;
Fluorides
;
Humans
;
Hypothermia*
;
Isometric Contraction
;
Male
;
Muscle, Smooth, Vascular
;
Nitric Oxide
;
Phosphorylation
;
Rats
;
Relaxation
;
rho-Associated Kinases*
2.Percutaneous closure of a patent ductus arteriosus guided by intravascular ultrasound.
Seung Bae YOON ; Ki Dong YOO ; Ji Hoon KIM ; Eun Joo IM ; Jeong Woo LEE ; Keon Woong MOON ; Chul Min KIM
Korean Journal of Medicine 2009;77(2):181-183
No abstract available.
Ductus Arteriosus, Patent
3.High Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Medulloblastoma/Primitive Neuroectodermal Tumor.
Ki Woong SUNG ; Keon Hee YOO ; Hong Hoe KOO ; Do Hoon LIM ; Hyung Jin SHIN ; Yoon Jeong KIM ; Seung Do AHN ; Young Shin RA ; Thad T GHIM
Korean Journal of Pediatric Hematology-Oncology 2001;8(2):264-272
PURPOSE: To improve survival and/or to avoid radiotherapy, high dose chemotherapy (HDCT) with autologous peripheral blood stem cell transplantation (PBSCT) was given to patients with recurrent or high risk medulloblastoma (MB)/primitive neuroectodermal tumor (PNET) as well as patients younger than 3 years of age. METHODS: Six patients (3 recurrent, 1 high risk, 2 younger than 3 years; 5 MBs and 1 PNET) received single or double HDCT and PBSCT with or without immunotherapy using interleukin-2. Chemotherapeutic regimen in the first HDCT included cyclophosphamide (1,500 mg/m2/ day for 4 days) and melphalan (60 mg/m2/day for 3 days). Chemotherapeutic regimen in the second HDCT included carboplatin (400 mg/m2/day for 3 days), thiotepa (250 mg/ m2/day for 3 days), and etoposide (200 mg/m2/day for 3 days). RESULTS: Nine HDCTs were applied in 6 patients. Three double HDCTs were rescued with peripheral blood stem cells collected during single round leukapheresis. Rapid hematologic recovery occurred in 4 patients. Engraft failure occurred in 1 patient and delayed granulocyte recovery and platelet engraft failure occurred in 1 patient. Three patients who had minimal disease before HDCT had event free survival for 7~18 months after HDCT. Tumor relapsed 8 and 12 months after single HDCT in 2 patients among 3 patients with recurrent MB/PNET. One patient with recurrent MB died due to engraft failure and sepsis. CONCLUSION: HDCT with autologous PBSCT is expected to improve survival of patients with poor prognosis MB/PNET including younger patients less than 3 years. Subsequent trials with larger number of patients and long-term follow-up are needed.
Blood Platelets
;
Carboplatin
;
Cyclophosphamide
;
Disease-Free Survival
;
Drug Therapy*
;
Etoposide
;
Follow-Up Studies
;
Granulocytes
;
Humans
;
Immunotherapy
;
Interleukin-2
;
Leukapheresis
;
Medulloblastoma
;
Melphalan
;
Neural Plate*
;
Neuroectodermal Tumors*
;
Neuroectodermal Tumors, Primitive
;
Peripheral Blood Stem Cell Transplantation*
;
Prognosis
;
Radiotherapy
;
Sepsis
;
Stem Cells
;
Thiotepa
4.Extremely Low Frequency Magnetic Field Modulates the Level of Neurotransmitters.
Yoon Hee CHUNG ; Young Joo LEE ; Ho Sung LEE ; Su Jin CHUNG ; Cheol Hee LIM ; Keon Woong OH ; Uy Dong SOHN ; Eon Sub PARK ; Ji Hoon JEONG
The Korean Journal of Physiology and Pharmacology 2015;19(1):15-20
This study was aimed to observe that extremely low frequency magnetic field (ELF-MF) may be relevant to changes of major neurotransmitters in rat brain. After the exposure to ELF-MF (60 Hz, 2.0 mT) for 2 or 5 days, we measured the levels of biogenic amines and their metabolites, amino acid neurotransmitters and nitric oxide (NO) in the cortex, striatum, thalamus, cerebellum and hippocampus. The exposure of ELF-MF for 2 or 5 days produced significant differences in norepinephrine and vanillyl mandelic acid in the striatum, thalamus, cerebellum and hippocampus. Significant increases in the levels of serotonin and 5-hydroxyindoleacetic acid were also observed in the striatum, thalamus or hippocampus. ELF-MF significantly increased the concentration of dopamine in the thalamus. ELF-MF tended to increase the levels of amino acid neurotransmitters such as glutamine, glycine and gamma -aminobutyric acid in the striatum and thalamus, whereas it decreased the levels in the cortex, cerebellum and hippocampus. ELF-MF significantly increased NO concentration in the striatum, thalamus and hippocampus. The present study has demonstrated that exposure to ELF-MFs may evoke the changes in the levels of biogenic amines, amino acid and NO in the brain although the extent and property vary with the brain areas. However, the mechanisms remain further to be characterized.
Animals
;
Biogenic Amines
;
Brain
;
Cerebellum
;
Dopamine
;
Glutamine
;
Glycine
;
Hippocampus
;
Magnetic Fields*
;
Neurotransmitter Agents*
;
Nitric Oxide
;
Norepinephrine
;
Rats
;
Serotonin
;
Thalamus
5.Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1
Min-Ju KIM ; Ki Back CHU ; Keon-Woong YOON ; Hae-Ji KANG ; Dong-Hun LEE ; Eun-Kyung MOON ; Fu-Shi QUAN
Parasites, Hosts and Diseases 2024;62(2):193-204
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
6.Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1
Min-Ju KIM ; Ki Back CHU ; Keon-Woong YOON ; Hae-Ji KANG ; Dong-Hun LEE ; Eun-Kyung MOON ; Fu-Shi QUAN
Parasites, Hosts and Diseases 2024;62(2):193-204
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
7.Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1
Min-Ju KIM ; Ki Back CHU ; Keon-Woong YOON ; Hae-Ji KANG ; Dong-Hun LEE ; Eun-Kyung MOON ; Fu-Shi QUAN
Parasites, Hosts and Diseases 2024;62(2):193-204
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
8.Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1
Min-Ju KIM ; Ki Back CHU ; Keon-Woong YOON ; Hae-Ji KANG ; Dong-Hun LEE ; Eun-Kyung MOON ; Fu-Shi QUAN
Parasites, Hosts and Diseases 2024;62(2):193-204
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
9.Establishment and Management of Pediatric Tumor Tissue Bank.
Hye Lim JUNG ; Dong Hyun KIM ; Su Yeun KIM ; Keon Hee YOO ; Ki Woong SUNG ; Hong Hoe KOO ; Suk Koo LEE ; Hyung Jin SHIN ; Jhin Gook KIM ; Hye Kyung YOON
Korean Journal of Pediatric Hematology-Oncology 2001;8(2):314-322
PURPOSE: Current pediatric cancer research requires an organized pediatric tumor tissue bank with standardized guidelines for preparation and storage of human tumor tissue samples, white cells, serum, genomic DNA, RNA, cDNA and proteins.. Our institution established and managed pediatric tumor tissue bank for the last one year, and we want to present an overview of our experiences and guidelines. METHODS: From leukemia patients, peripheral blood and bone marrow aspirates were collected at initial diagnosis. Leukemic cells were prepared by Ficoll density-gradient centrifugation and stored at 196oC liquid nitrogen. For solid tumors, tissue cultures were performed as soon as possible after surgical excision or needle biopsy. Serum free media and primary cultured cells were collected and stored at 20degrees C and at 196degrees C, respectively. Genomic DNA, RNA and cDNA were isolated from leukemic cells and cultured solid tumor cells, and stored at 20degrees C. We also isolated genomic DNA from white blood cells of solid tumor patients and stored at 20degrees C. Finally we collected serum samples from all pediatric cancer patients at diagnosis and stored at 20degrees C. RESULTS: Among the 41 cases of leukemia and 100 cases of solid tumor patients who were diagnosed at department of pediatrics, Samsung Medical Center, from August 2000 to July 2001, 26 cases (63%) of leukemia and 59 cases (59%) of solid tumor patients were registered to Pediatric Tumor Tissue Bank. Primary cell cultures were performed in 21 cases of solid tumors and were successful in 19 cases (90%). The isolated genomic DNA, RNA and cDNA were all in high quality confirmed by electrophoresis in agarose gel. CONCLUSION: The problem of tissue sample size obtained by needle biopsy could be overcome by primary cell cultures. For the effective management of pediatric tumor tissue bank, fresh tissue collection with active cooperation of surgeons, organized personnel structure, and multidisciplinary standardized guidelines are necessary.
Biopsy, Needle
;
Bone Marrow
;
Cell Culture Techniques
;
Cells, Cultured
;
Centrifugation
;
Culture Media, Serum-Free
;
Diagnosis
;
DNA
;
DNA, Complementary
;
Electrophoresis
;
Ficoll
;
Humans
;
Leukemia
;
Leukocytes
;
Nitrogen
;
Pediatrics
;
Primary Cell Culture
;
RNA
;
Sample Size
;
Sepharose
;
Tissue Banks*
10.The metabolic syndrome and body composition in childhood cancer survivors.
Young Bae SOHN ; Su Jin KIM ; Sung Won PARK ; Se Hwa KIM ; Sung Yoon CHO ; Soo Hyun LEE ; Keon Hee YOO ; Ki Woong SUNG ; Jae Hoon CHUNG ; Hong Hoe KOO ; Dong Kyu JIN
Korean Journal of Pediatrics 2011;54(6):253-259
PURPOSE: Long-term survivors of childhood cancer appear to have an increased risk for the metabolic syndrome, subsequent type 2 diabetes and cardiovascular disease in adulthood compared to healthy children. The purpose of this study was to investigate the frequency of the metabolic syndrome and associated factors in childhood cancer survivors at a single center in Korea. METHODS: We performed a retrospective review of medical records of 98 childhood cancer survivors who were diagnosed and completed anticancer treatment at Samsung Medical Center, Seoul, Korea between Jan. 1996 and Dec. 2007. Parameters of metabolic syndrome were evaluated between Jan. 2008 and Dec. 2009. Clinical and biochemical findings including body fat percentage were analyzed. RESULTS: A total of 19 (19.4%) patients had the metabolic syndrome. The median body fat percentage was 31.5%. The body mass index and waist circumference were positively correlated with the cranial irradiation dose (r=0.38, P<0.001 and r=0.44, P<0.00, respectively). Sixty-one (62.2%) patients had at least one abnormal lipid value. The triglyceride showed significant positive correlation with the body fat percentage (r=0.26, P=0.03). The high density lipoprotein cholesterol showed significant negative correlation with the percent body fat (r=-0.26, P=0.03). CONCLUSION: Childhood cancer survivors should have thorough metabolic evaluation including measurement of body fat percentage even if they are not obese. A better understanding of the determinants of the metabolic syndrome during adolescence might provide preventive interventions for improving health outcomes in adulthood.
Adipose Tissue
;
Adolescent
;
Body Composition
;
Body Mass Index
;
Cardiovascular Diseases
;
Child
;
Cholesterol
;
Cholesterol, HDL
;
Cranial Irradiation
;
Humans
;
Korea
;
Lipoproteins
;
Medical Records
;
Retrospective Studies
;
Survivors
;
Waist Circumference